<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38390594</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome?</ArticleTitle><Pagination><StartPage>1344862</StartPage><MedlinePgn>1344862</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1344862</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2024.1344862</ELocationID><Abstract><AbstractText>Dysautonomia, or dysfunction of the autonomic nervous system (ANS), may occur following an infectious insult and can result in a variety of debilitating, widespread, and often poorly recognized symptoms. Dysautonomia is now widely accepted as a complication of COVID-19 and is an important component of Post-Acute Sequelae of COVID-19 (PASC or long COVID). PASC shares many overlapping clinical features with other infection-associated chronic illnesses including Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Post-Treatment Lyme Disease Syndrome (PTLDS), suggesting that they may share common underlying mechanisms including autonomic dysfunction. Despite the recognition of this complication of Lyme disease in the care of patients with PTLD, there has been a scarcity of research in this field and dysautonomia has not yet been established as a complication of Lyme disease in the medical literature. In this review, we discuss the evidence implicating <i>Borrelia burgdorferi</i> as a cause of dysautonomia and the related symptoms, propose potential pathogenic mechanisms given our knowledge of Lyme disease and mechanisms of PASC and ME/CFS, and discuss the diagnostic evaluation and treatments of dysautonomia. We also outline gaps in the literature and priorities for future research.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Adler, Chung, Rowe and Aucott.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adler</LastName><ForeName>Brittany L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Johns Hopkins University, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Tae</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Johns Hopkins University, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowe</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Johns Hopkins University, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aucott</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Johns Hopkins University, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Borrelia (Borreliella) burgdorferi</Keyword><Keyword MajorTopicYN="N">Lyme disease</Keyword><Keyword MajorTopicYN="N">dysautonomia</Keyword><Keyword MajorTopicYN="N">post-treatment Lyme disease (PTLD)</Keyword><Keyword MajorTopicYN="N">postural orthostatic tachycardia syndrome (POTS)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>4</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38390594</ArticleId><ArticleId IdType="pmc">PMC10883079</ArticleId><ArticleId IdType="doi">10.3389/fneur.2024.1344862</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arnold AC, Ng J, Raj SR. Postural tachycardia syndrome &#x2013; diagnosis, physiology, and prognosis. Auton Neurosci. (2018) 215:3&#x2013;11. 10.1016/j.autneu.2018.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2018.02.005</ArticleId><ArticleId IdType="pmc">PMC6113123</ArticleId><ArticleId IdType="pubmed">29523389</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehr SE, Barbul A, Shibao CA. Gastrointestinal symptoms in postural tachycardia syndrome: a systematic review. Clin Auton Res. (2018) 28:411&#x2013;21. 10.1007/s10286-018-0519-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-018-0519-x</ArticleId><ArticleId IdType="pmc">PMC6314490</ArticleId><ArticleId IdType="pubmed">29549458</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw BH, Stiles LE, Bourne K, Green EA, Shibao CA, Okamoto LE, et al. . The face of postural tachycardia syndrome &#x2013; insights from a large cross-sectional online community-based survey. J Intern Med. (2019) 286:438&#x2013;48. 10.1111/joim.12895</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12895</ArticleId><ArticleId IdType="pmc">PMC6790699</ArticleId><ArticleId IdType="pubmed">30861229</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. (2021) 69:205&#x2013;11. 10.1007/s12026-021-09185-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-021-09185-5</ArticleId><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. (2020) 30:449&#x2013;51. 10.1007/s10286-020-00727-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00727-9</ArticleId><ArticleId IdType="pmc">PMC7471493</ArticleId><ArticleId IdType="pubmed">32880754</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen CLMC, Visser FC. Orthostatic intolerance in long-haul COVID after SARS-CoV-2: a case-control comparison with post-EBV and insidious-onset myalgic encephalomyelitis/chronic fatigue syndrome patients. Healthcare. (2022) 10:2058. 10.3390/healthcare10102058</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10102058</ArticleId><ArticleId IdType="pmc">PMC9602265</ArticleId><ArticleId IdType="pubmed">36292504</ArticleId></ArticleIdList></Reference><Reference><Citation>Carod-Artal FJ. Infectious diseases causing autonomic dysfunction. Clin Auton Res. (2018) 28:67&#x2013;81. 10.1007/s10286-017-0452-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-017-0452-4</ArticleId><ArticleId IdType="pubmed">28730326</ArticleId></ArticleIdList></Reference><Reference><Citation>Aucott JN. Posttreatment Lyme disease syndrome. Infect Dis Clin. (2015) 29:309&#x2013;23. 10.1016/j.idc.2015.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2015.02.012</ArticleId><ArticleId IdType="pubmed">25999226</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein DS, Robertson D, Esler M, Straus SE, Eisenhofer G. Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med. (2002) 137:753&#x2013;63. 10.7326/0003-4819-137-9-200211050-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-137-9-200211050-00011</ArticleId><ArticleId IdType="pubmed">12416949</ArticleId></ArticleIdList></Reference><Reference><Citation>Low PA, Sandroni P, Joyner M, Shen WK. Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol. (2009) 20:352&#x2013;8. 10.1111/j.1540-8167.2008.01407.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2008.01407.x</ArticleId><ArticleId IdType="pmc">PMC3904426</ArticleId><ArticleId IdType="pubmed">19207771</ArticleId></ArticleIdList></Reference><Reference><Citation>Evenson S. &#x201c;But You Don't Look Sick&#x201d;: Medical Gaslighting and Disability Identity Among Individuals Living with POTS and ME/CFS. Thesis. (2021). Available online at: https://scholarship.tricolib.brynmawr.edu/handle/10066/23717 (accessed September 9, 2022).</Citation></Reference><Reference><Citation>Grubb BP. Postural tachycardia syndrome. Circulation. (2008) 117:2814&#x2013;7. 10.1161/CIRCULATIONAHA.107.761650</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.761650</ArticleId><ArticleId IdType="pubmed">18506020</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. . Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci. (2011) 161:46&#x2013;8. 10.1016/j.autneu.2011.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2011.02.004</ArticleId><ArticleId IdType="pubmed">21393070</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe PC, Calkins H, DeBusk K, McKenzie R, Anand R, Sharma G, et al. . Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA. (2001) 285:52&#x2013;9. 10.1001/jama.285.1.52</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.285.1.52</ArticleId><ArticleId IdType="pubmed">11150109</ArticleId></ArticleIdList></Reference><Reference><Citation>Low PA, Opfer-Gehrking TL, Textor SC, Schondorf R, Suarez GA, Fealey RD, et al. . Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure. J Auton Nerv Syst. (1994) 50:181&#x2013;8. 10.1016/0165-1838(94)90008-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1838(94)90008-6</ArticleId><ArticleId IdType="pubmed">7884158</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. J Intern Med. (2019) 285:352&#x2013;66. 10.1111/joim.12852</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12852</ArticleId><ArticleId IdType="pubmed">30372565</ArticleId></ArticleIdList></Reference><Reference><Citation>Hira R, Baker JR, Siddiqui T, Ranada SI, Soroush A, Karalasingham K, et al. . Objective hemodynamic cardiovascular autonomic abnormalities in post-acute sequelae of COVID-19. Can J Cardiol. (2023) 39:767&#x2013;75. 10.1016/j.cjca.2023.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2023.09.005</ArticleId><ArticleId IdType="pmc">PMC9733966</ArticleId><ArticleId IdType="pubmed">36509178</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen CLMC, Rowe PC, Visser FC. Cerebral blood flow remains reduced after tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome patients. Clin Neurophysiol. Pract. (2021) 6:245&#x2013;55. 10.1016/j.cnp.2021.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnp.2021.09.001</ArticleId><ArticleId IdType="pmc">PMC8505270</ArticleId><ArticleId IdType="pubmed">34667909</ArticleId></ArticleIdList></Reference><Reference><Citation>Roma M, Marden CL, De Wandele I, Francomano CA, Rowe PC. Postural tachycardia syndrome and other forms of orthostatic intolerance in Ehlers-Danlos syndrome. Auton Neurosci. (2018) 215:89&#x2013;96. 10.1016/j.autneu.2018.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2018.02.006</ArticleId><ArticleId IdType="pubmed">29519641</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons CH, Bonyhay I, Benson A, Wang N, Freeman R. Structural and functional small fiber abnormalities in the neuropathic postural tachycardia syndrome. PLoS ONE. (2013) 8:e0084716. 10.1371/journal.pone.0084716</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0084716</ArticleId><ArticleId IdType="pmc">PMC3874039</ArticleId><ArticleId IdType="pubmed">24386408</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi A, Baker K, Jeanmonod D, Jeanmonod R. Lyme disease presenting with multiple cranial nerve deficits: report of a case. Case Rep Emerg Med. (2016) 2016:7218906. 10.1155/2016/7218906</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/7218906</ArticleId><ArticleId IdType="pmc">PMC5011200</ArticleId><ArticleId IdType="pubmed">27635267</ArticleId></ArticleIdList></Reference><Reference><Citation>Halperin J. Nervous System Lyme Disease.
UpToDate:  (2021). Available online at: https://www.uptodate.com/contents/nervous-system-lyme-disease (Retrieved July 18, 2023).</Citation></Reference><Reference><Citation>Petrun AM, Sinkovi&#x10d; A. Borreliosis presenting as autonomic nervous dysfunction, phrenic nerve palsy with respiratory failure and myocardial dysfunction &#x2014; a case report. Cent Eur J Med. (2013) 8:463&#x2013;7. 10.2478/s11536-013-0172-7</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/s11536-013-0172-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Younger DS, Orsher S. Lyme neuroborreliosis: preliminary results from an urban referral center employing strict CDC criteria for case selection. Neurol Res Int. (2010) 2010:525206. 10.1155/2010/525206</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2010/525206</ArticleId><ArticleId IdType="pmc">PMC2989654</ArticleId><ArticleId IdType="pubmed">21188224</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatila R, Kapadia CR. Intestinal pseudoobstruction in acute Lyme disease: a case report. Am J Gastroenterol. (1998) 93:1179&#x2013;80. 10.1111/j.1572-0241.1998.00361.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1572-0241.1998.00361.x</ArticleId><ArticleId IdType="pubmed">9672362</ArticleId></ArticleIdList></Reference><Reference><Citation>Schefte DF, Nordentoft T. Intestinal pseudoobstruction caused by chronic lyme neuroborreliosis. A case report. J Neurogastroenterol Motil. (2015) 21:440. 10.5056/jnm14118</Citation><ArticleIdList><ArticleId IdType="doi">10.5056/jnm14118</ArticleId><ArticleId IdType="pmc">PMC4496901</ArticleId><ArticleId IdType="pubmed">26130639</ArticleId></ArticleIdList></Reference><Reference><Citation>Autschbach R, Zaremba A, Ulrich B. Pseudo-obstruction of the colon following tick bite injury. Chirurg. (1989) 60:365&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">2737028</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone M, Iqbal A, Hugo Bonatti JR, Anwar S, Feaga C. A patient with SIADH, urinary retention, constipation, and Bell's palsy following a tick bite. Case Rep Nephrol. (2022) 2022:5937131. 10.1155/2022/5937131</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/5937131</ArticleId><ArticleId IdType="pmc">PMC9293531</ArticleId><ArticleId IdType="pubmed">35859789</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamim EA, Shamim SA, Liss G, Nylen E, Pincus JH, Yepes M. Constipation heralding neuroborreliosis: an atypical tale of 2 patients. Arch Neurol. (2005) 62:671&#x2013;3. 10.1001/archneur.62.4.671</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.62.4.671</ArticleId><ArticleId IdType="pubmed">15824271</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen BA, Finjord T, Bruserud &#xd8;. Autonomous dysfunction in Lyme neuroborreliosis. A case report. Clin Case Rep. (2018) 6:901. 10.1002/ccr3.1494</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.1494</ArticleId><ArticleId IdType="pmc">PMC5930201</ArticleId><ArticleId IdType="pubmed">29744083</ArticleId></ArticleIdList></Reference><Reference><Citation>Burman M, Nguyen HL, Murthy V, Gupta PS, Davies C, Wragg A, et al. . Severe orthostatic hypotension in a diabetic patient may not be due to diabetic autonomic neuropathy. Clin Med. (2011) 11:290. 10.7861/clinmedicine.11-3-290</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.11-3-290</ArticleId><ArticleId IdType="pmc">PMC4953329</ArticleId><ArticleId IdType="pubmed">21902089</ArticleId></ArticleIdList></Reference><Reference><Citation>Gila L, Guerrero A, Astarloa R, Mart&#xed; P, Guti&#xe9;rrez JM. Reflex sympathetic dystrophy. A new manifestation of Lyme disease? Enferm Infecc Microbiol Clin. (1990) 8:32&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">2095902</ArticleId></ArticleIdList></Reference><Reference><Citation>Puri BK, Shah M, Monro JA, Kingston MC, Julu PO. Respiratory modulation of cardiac vagal tone in Lyme disease. World J Cardiol. (2014) 6:502. 10.4330/wjc.v6.i6.502</Citation><ArticleIdList><ArticleId IdType="doi">10.4330/wjc.v6.i6.502</ArticleId><ArticleId IdType="pmc">PMC4072840</ArticleId><ArticleId IdType="pubmed">24976922</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes PJ, Lane RJ, Cutler SJ, Wright DJ, Abraham RM, Wade JP, et al. . Small-fiber dysfunction in a Borrelia burgdorferi infection. Muscle Nerve. (1993) 16:221&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">8381520</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuer N, Alaedini A. Resolution of pain in the absence of nerve regeneration in small fiber neuropathy following treatment of Lyme disease (P06.228). Neurology. (2013) 80(7 Supplement):P06.228. 10.1212/WNL.80.7_supplement.P06.228</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.80.7_supplement.P06.228</ArticleId></ArticleIdList></Reference><Reference><Citation>Duray PH. Histopathology of clinical phases of human Lyme disease. Rheum Dis Clin North Am. (1989) 15:691&#x2013;710. 10.1016/S0889-857X(21)01023-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0889-857X(21)01023-1</ArticleId><ArticleId IdType="pubmed">2685926</ArticleId></ArticleIdList></Reference><Reference><Citation>Duray PH. The surgical pathology of human Lyme disease: an enlarging picture. Am J Surg Pathol. (1987) 11:47&#x2013;60. 10.1097/00000478-198700111-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000478-198700111-00005</ArticleId><ArticleId IdType="pubmed">3812878</ArticleId></ArticleIdList></Reference><Reference><Citation>Duray PH, Steere AC. Clinical pathologic correlations of Lyme disease by stage. Ann NY Acad Sci. (1988) 539(1 Lyme Disease):65&#x2013;79. 10.1111/j.1749-6632.1988.tb31839.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.1988.tb31839.x</ArticleId><ArticleId IdType="pubmed">2847622</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts ED, Bohm RP Jr, Cogswell FB, Lanners HN, Lowrie RC Jr, Povinelli L, et al. . Chronic Lyme disease in the rhesus monkey. Lab Invest. (1995) 72:146&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">7853849</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh G, Borda JT, Gill A, Ribka EP, Morici LA, Mottram P, et al. . Possible role of glial cells in the onset and progression of Lyme neuroborreliosis. J Neuroinflammation. (2009) 6:1&#x2013;16. 10.1186/1742-2094-6-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-6-23</ArticleId><ArticleId IdType="pmc">PMC2748066</ArticleId><ArticleId IdType="pubmed">19706181</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh G, Santana-Gould L, Inglis FM, England JD, Philipp MT. The Lyme disease spirochete Borrelia burgdorferi induces inflammation and apoptosis in cells from dorsal root ganglia. J Neuroinflammation. (2013) 10:1&#x2013;14. 10.1186/1742-2094-10-88</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-10-88</ArticleId><ArticleId IdType="pmc">PMC3721987</ArticleId><ArticleId IdType="pubmed">23866773</ArticleId></ArticleIdList></Reference><Reference><Citation>Aucott JN, Yang T, Yoon I, Powell D, Geller SA, Rebman AW. Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: a prospective cohort study. Int J Infect Dis. (2022) 116:230&#x2013;7. 10.1016/j.ijid.2022.01.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.01.033</ArticleId><ArticleId IdType="pubmed">35066160</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebman AW, Bechtold KT, Yang T, Mihm EA, Soloski MJ, Novak CB, et al. . The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment Lyme disease syndrome. Front Med. (2017) 4:224. 10.3389/fmed.2017.00224</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2017.00224</ArticleId><ArticleId IdType="pmc">PMC5735370</ArticleId><ArticleId IdType="pubmed">29312942</ArticleId></ArticleIdList></Reference><Reference><Citation>Puri BK, Shah M, Julu PO, Kingston MC, Monro JA. Urinary bladder detrusor dysfunction symptoms in Lyme disease. Int Neurourol J. (2013) 17:127. 10.5213/inj.2013.17.3.127</Citation><ArticleIdList><ArticleId IdType="doi">10.5213/inj.2013.17.3.127</ArticleId><ArticleId IdType="pmc">PMC3797892</ArticleId><ArticleId IdType="pubmed">24143291</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Postural orthostatic tachycardia syndrome following Lyme disease. Cardiol J. (2011) 18:63&#x2013;6. 10.1097/MJT.0b013e3181da0763</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MJT.0b013e3181da0763</ArticleId><ArticleId IdType="pubmed">21305487</ArticleId></ArticleIdList></Reference><Reference><Citation>Noyes AM, Kluger J. A tale of two syndromes: Lyme disease preceding postural orthostatic tachycardia syndrome. Ann Noninvasive Electrocardiol. (2015) 20:82&#x2013;6. 10.1111/anec.12158</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anec.12158</ArticleId><ArticleId IdType="pmc">PMC6931862</ArticleId><ArticleId IdType="pubmed">24830783</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P, Felsenstein D, Mao C, Octavien NR, Zubcevik N. Association of small fiber neuropathy and post treatment Lyme disease syndrome. PLoS ONE. (2019) 14:e0212222. 10.1371/journal.pone.0212222</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0212222</ArticleId><ArticleId IdType="pmc">PMC6372188</ArticleId><ArticleId IdType="pubmed">30753241</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheirkhah A, Darabad RR, Cruzat A, Hajrasouliha AR, Witkin D, Wong N, et al. . Corneal epithelial immune dendritic cell alterations in subtypes of dry eye disease: a pilot in vivo confocal microscopic study. Invest Ophthalmol Vis Sci. (2015) 56:7179&#x2013;85. 10.1167/iovs.15-17433</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.15-17433</ArticleId><ArticleId IdType="pmc">PMC4640475</ArticleId><ArticleId IdType="pubmed">26540656</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz RI, Freeman PR. Precision medicine: retrospective chart review and data analysis of 200 patients on dapsone combination therapy for chronic Lyme disease/post-treatment Lyme disease syndrome: part 1. Int J Gen Med. (2019) 12:101&#x2013;19. 10.2147/IJGM.S193608</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S193608</ArticleId><ArticleId IdType="pmc">PMC6388746</ArticleId><ArticleId IdType="pubmed">30863136</ArticleId></ArticleIdList></Reference><Reference><Citation>Mietze A, Strube C, Beyerbach M, Schnieder T, Goethe R. Occurrence of Bartonella henselae and Borrelia burgdorferi sensu lato co-infections in ticks collected from humans in Germany. Clin Microbiol Infect. (2011) 17:918&#x2013;20. 10.1111/j.1469-0691.2010.03363.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2010.03363.x</ArticleId><ArticleId IdType="pubmed">21682805</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayne PJ. Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis, and ehrlichiosis in an Australian cohort. Int J Gen Med. (2014) 8:15&#x2013;26. 10.2147/IJGM.S75825</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S75825</ArticleId><ArticleId IdType="pmc">PMC4278782</ArticleId><ArticleId IdType="pubmed">25565883</ArticleId></ArticleIdList></Reference><Reference><Citation>Logigian EL, Steere AC. Clinical and electrophysiologic findings in chronic neuropathy of Lyme disease. Neurology. (1992) 42:303&#x2013;303. 10.1212/WNL.42.2.303</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.42.2.303</ArticleId><ArticleId IdType="pubmed">1310529</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers TA, Kaushal D, Philipp MT. Microglia are mediators of Borrelia burgdorferi&#x2013;induced apoptosis in SH-SY5Y neuronal cells. PLoS Pathog. (2009) 5:e1000659. 10.1371/journal.ppat.1000659</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000659</ArticleId><ArticleId IdType="pmc">PMC2771360</ArticleId><ArticleId IdType="pubmed">19911057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh G, Alvarez AL, Roberts ED, Dennis VA, Lasater BL, Alvarez X, et al. . Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes. Eur J Immunol. (2003) 33:2539&#x2013;50. 10.1002/eji.200323872</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200323872</ArticleId><ArticleId IdType="pubmed">12938230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh G, Didier PJ, England JD, Santana-Gould L, Doyle-Meyers LA, Martin DS, et al. . Inflammation in the pathogenesis of Lyme neuroborreliosis. Am J Pathol. (2015) 185:1344&#x2013;60. 10.1016/j.ajpath.2015.01.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2015.01.024</ArticleId><ArticleId IdType="pmc">PMC4419210</ArticleId><ArticleId IdType="pubmed">25892509</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh G, Borda JT, Dufour J, Kaushal D, Ramamoorthy R, Lackner AA, et al. . Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis. Am J Pathol. (2008) 173:1415&#x2013;27. 10.2353/ajpath.2008.080483</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.080483</ArticleId><ArticleId IdType="pmc">PMC2570132</ArticleId><ArticleId IdType="pubmed">18832582</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh G, Meisner OC, Philipp MT. Anti-inflammatory effects of dexamethasone and meloxicam on Borrelia burgdorferi-induced inflammation in neuronal cultures of dorsal root ganglia and myelinating cells of the peripheral nervous system. J Neuroinflammation. (2015) 12:1&#x2013;12. 10.1186/s12974-015-0461-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0461-y</ArticleId><ArticleId IdType="pmc">PMC4690425</ArticleId><ArticleId IdType="pubmed">26700298</ArticleId></ArticleIdList></Reference><Reference><Citation>Embers ME, Hasenkampf NR, Jacobs MB, Tardo AC, Doyle-Meyers LA, Philipp MT, et al. . Variable manifestations, diverse seroreactivity and post-treatment persistence in non-human primates exposed to Borrelia burgdorferi by tick feeding. PLoS ONE. (2017) 12:e0189071. 10.1371/journal.pone.0189071</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0189071</ArticleId><ArticleId IdType="pmc">PMC5728523</ArticleId><ArticleId IdType="pubmed">29236732</ArticleId></ArticleIdList></Reference><Reference><Citation>Embers ME, Barthold SW, Borda JT, Bowers L, Doyle L, Hodzic E, et al. . Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS ONE. (2012) 7:e29914. 10.1371/journal.pone.0029914</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0029914</ArticleId><ArticleId IdType="pmc">PMC3256191</ArticleId><ArticleId IdType="pubmed">22253822</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudenko N, Golovchenko M, Vancova M, Clark K, Grubhoffer L, Oliver JH. Isolation of live Borrelia burgdorferi sensu lato spirochaetes from patients with undefined disorders and symptoms not typical for Lyme borreliosis. Clin Microbiol Infect. (2016) 22:267.e9&#x2013;15. 10.1016/j.cmi.2015.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2015.11.009</ArticleId><ArticleId IdType="pubmed">26673735</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudson BJ, Stewart M, Lennox VA, Fukunaga M, Yabuki M, Macorison H, et al. . Culture-positive Lyme borreliosis. Med J Aust. (1998) 168:500&#x2013;2. 10.5694/j.1326-5377.1998.tb141415.x</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/j.1326-5377.1998.tb141415.x</ArticleId><ArticleId IdType="pubmed">9631675</ArticleId></ArticleIdList></Reference><Reference><Citation>Oksi J, Marjamaki M, Nikoskelainen J, Viljanen MK. Bowelia burgorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis. Ann Med. (1999) 31:225&#x2013;32. 10.3109/07853899909115982</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853899909115982</ArticleId><ArticleId IdType="pubmed">10442678</ArticleId></ArticleIdList></Reference><Reference><Citation>Had&#x17e;avdi&#x107; SL, Bartoli&#x107; L, Bradamante M. Granulomatous hepatitis associated with chronic Borrelia burgdorferi infection: a case report. Research. (2014) 1:875. 10.13070/rs.en.1.875</Citation><ArticleIdList><ArticleId IdType="doi">10.13070/rs.en.1.875</ArticleId></ArticleIdList></Reference><Reference><Citation>Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP, et al. . Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. (2001) 345:85&#x2013;92. 10.1056/NEJM200107123450202</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200107123450202</ArticleId><ArticleId IdType="pubmed">11450676</ArticleId></ArticleIdList></Reference><Reference><Citation>Trouillas P, Franck M. Complete remission in paralytic late tick-borne neurological disease comprising mixed involvement of Borrelia, Babesia, Anaplasma, and Bartonella: use of long-term treatments with antibiotics and antiparasitics in a series of 10 cases. Antibiotics. (2023) 12:1021. 10.3390/antibiotics12061021</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics12061021</ArticleId><ArticleId IdType="pmc">PMC10294829</ArticleId><ArticleId IdType="pubmed">37370340</ArticleId></ArticleIdList></Reference><Reference><Citation>Alruwaili Y, Jacobs MB, Hasenkampf NR, Tardo AC, McDaniel CE, Embers ME. Superior efficacy of combination antibiotic therapy versus monotherapy in a mouse model of Lyme disease. Front Microbiol. (2023) 14:1293300. 10.3389/fmicb.2023.1293300</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1293300</ArticleId><ArticleId IdType="pmc">PMC10703379</ArticleId><ArticleId IdType="pubmed">38075920</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlin JM, Yang T, Rebman AW, Bechtold KT, Du Y, Mathews WB, et al. . Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET. J Neuroinflammation. (2018) 15:1&#x2013;7. 10.1186/s12974-018-1381-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1381-4</ArticleId><ArticleId IdType="pmc">PMC6299943</ArticleId><ArticleId IdType="pubmed">30567544</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, et al. . Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: an 11C-(R)-PK11195 PET study. J Nucl Med. (2014) 55:945&#x2013;50. 10.2967/jnumed.113.131045</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.113.131045</ArticleId><ArticleId IdType="pubmed">24665088</ArticleId></ArticleIdList></Reference><Reference><Citation>Casselli T, Divan A, Vomhof-DeKrey EE, Tourand Y, Pecoraro HL, Brissette CA. A murine model of Lyme disease demonstrates that Borrelia burgdorferi colonizes the dura mater and induces inflammation in the central nervous system. PLoS Pathog. (2021) 17:e1009256. 10.1371/journal.ppat.1009256</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009256</ArticleId><ArticleId IdType="pmc">PMC7877756</ArticleId><ArticleId IdType="pubmed">33524035</ArticleId></ArticleIdList></Reference><Reference><Citation>Parthasarathy G, Fevrier HB, Philipp MT. Non-viable Borrelia burgdorferi induce inflammatory mediators and apoptosis in human oligodendrocytes. Neurosci Lett. (2013) 556:200&#x2013;3. 10.1016/j.neulet.2013.10.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2013.10.032</ArticleId><ArticleId IdType="pmc">PMC3856578</ArticleId><ArticleId IdType="pubmed">24157855</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnoni V, Ilic K, Drakatos P, Petrinovic MM, Cash D, Steier J, et al. . Obstructive sleep apnea and multiple facets of a neuroinflammatory response: a narrative review. J Thorac Dis. (2022) 14:564. 10.21037/jtd-21-1231</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-21-1231</ArticleId><ArticleId IdType="pmc">PMC8902117</ArticleId><ArticleId IdType="pubmed">35280483</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q, Wang Y, Feng J, Cao J, Chen B. Intermittent hypoxia from obstructive sleep apnea may cause neuronal impairment and dysfunction in central nervous system: the potential roles played by microglia. Neuropsychiatr Dis Treat. (2013) 9:1077&#x2013;86. 10.2147/NDT.S49868</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S49868</ArticleId><ArticleId IdType="pmc">PMC3742344</ArticleId><ArticleId IdType="pubmed">23950649</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. eNeurologicalSci. (2020) 21:100276. 10.1016/j.ensci.2020.100276</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2020.100276</ArticleId><ArticleId IdType="pmc">PMC7502253</ArticleId><ArticleId IdType="pubmed">32984564</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P, Mukerji SS, Alabsi HS, Systrom D, Marciano SP, Felsenstein D, et al. . Multisystem involvement in post-acute sequelae of coronavirus disease 19. Ann Neurol. (2022) 91:367&#x2013;79. 10.1002/ana.26286</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26286</ArticleId><ArticleId IdType="pmc">PMC9011495</ArticleId><ArticleId IdType="pubmed">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>Campen CLMC, Rowe PC, Visser FC. Orthostatic symptoms and reductions in cerebral blood flow in long-haul COVID-19 patients: similarities with myalgic encephalomyelitis/chronic fatigue syndrome. Medicina. (2022) 58:28. 10.3390/medicina58010028</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010028</ArticleId><ArticleId IdType="pmc">PMC8778312</ArticleId><ArticleId IdType="pubmed">35056336</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda M, Huh Y, Ji RR. Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain. J Anesth. (2019) 33:131&#x2013;9. 10.1007/s00540-018-2579-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-018-2579-4</ArticleId><ArticleId IdType="pmc">PMC6813778</ArticleId><ArticleId IdType="pubmed">30448975</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohno R, Cannom DS, Olshansky B, Xi SC, Krishnappa D, Adkisson WO, et al. . Mast cell activation disorder and postural orthostatic tachycardia syndrome: a clinical association. J Am Heart Assoc. (2021) 10:e021002. 10.1161/JAHA.121.021002</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.021002</ArticleId><ArticleId IdType="pmc">PMC8649306</ArticleId><ArticleId IdType="pubmed">34398691</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Ackerley MB, Bluestein LS, Brewer JH, Brook JB, Buchanan AD, et al. . Diagnosis of mast cell activation syndrome: a global &#x201c;consensus-2&#x201d;. Diagnosis. (2021) 8:137&#x2013;52. 10.1515/dx-2020-0005</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/dx-2020-0005</ArticleId><ArticleId IdType="pubmed">32324159</ArticleId></ArticleIdList></Reference><Reference><Citation>Blennerhassett MG, Tomioka M, Bienenstock J. Formation of contacts between mast cells and sympathetic neurons in vitro. Cell Tissue Res. (1991) 265:121&#x2013;8. 10.1007/BF00318146</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00318146</ArticleId><ArticleId IdType="pubmed">1913774</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC. Mast cells: the immune gate to the brain. Life Sci. (1990) 46:607&#x2013;17. 10.1016/0024-3205(90)90129-F</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(90)90129-F</ArticleId><ArticleId IdType="pubmed">2407920</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong H, Zhang X, Qian Y. Mast cells and neuroinflammation. Med Sci Monit Basic Res. (2014) 20:200. 10.12659/MSMBR.893093</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSMBR.893093</ArticleId><ArticleId IdType="pmc">PMC4282993</ArticleId><ArticleId IdType="pubmed">25529562</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaper SD, Giusti P, Facci L. Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J. (2012) 26:3103&#x2013;17. 10.1096/fj.11-197194</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.11-197194</ArticleId><ArticleId IdType="pubmed">22516295</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra A, Wormser GP, Klempner MS, Trevino RP, Crow MK, Latov N, et al. . Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun. (2010) 24:1018&#x2013;24. 10.1016/j.bbi.2010.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.03.002</ArticleId><ArticleId IdType="pmc">PMC2897967</ArticleId><ArticleId IdType="pubmed">20227484</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccallini P, Bonin S, Trevisan G. Autoimmunity against a glycolytic enzyme as a possible cause for persistent symptoms in Lyme disease. Med Hypotheses. (2018) 110:1&#x2013;8. 10.1016/j.mehy.2017.10.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2017.10.024</ArticleId><ArticleId IdType="pubmed">29317049</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallon BA, Strobino B, Reim S, Stoner J, Cunningham MW. Anti-lysoganglioside and other anti-neuronal autoantibodies in post-treatment Lyme disease and erythema migrans after repeat infection. Brain Behav Immunity Health. (2020) 2:100015. 10.1016/j.bbih.2019.100015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2019.100015</ArticleId><ArticleId IdType="pmc">PMC8474536</ArticleId><ArticleId IdType="pubmed">34589824</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. (2000) 343:847&#x2013;55. 10.1056/NEJM200009213431204</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200009213431204</ArticleId><ArticleId IdType="pubmed">10995864</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M, Grabowski P, Heidecke H, Bauer S, Hanitsch LG, Wittke K, et al. . Antibodies to &#x3b2; adrenergic and muscarinic cholinergic receptors in patients with chronic fatigue syndrome. Brain Behav Immun. (2016) 52:32&#x2013;9. 10.1016/j.bbi.2015.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.09.013</ArticleId><ArticleId IdType="pubmed">26399744</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitag H, Szklarski M, Lorenz S, Sotzny F, Bauer S, Philippe A, et al. . Autoantibodies to vasoregulative g-protein-coupled receptors correlate with symptom severity, autonomic dysfunction and disability in myalgic encephalomyelitis/chronic fatigue syndrome. J Clin Med. (2021) 10:3675. 10.3390/jcm10163675</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10163675</ArticleId><ArticleId IdType="pmc">PMC8397061</ArticleId><ArticleId IdType="pubmed">34441971</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, F&#xfc;rst J, Schulze-Rothe S, Wallukat A, et al. . Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. (2021) 4:100100. 10.1016/j.jtauto.2021.100100</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez B, Hoepner R, Salmen A, Kamber N. Z'Graggen WJ. Immunomodulatory treatment in postural tachycardia syndrome: a case series. Eur J Neurol. (2021) 28:1692&#x2013;7. 10.1111/ene.14711</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14711</ArticleId><ArticleId IdType="pubmed">33382525</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesterson K, Schofield J, Blitshteyn S. Immunotherapy with subcutaneous immunoglobulin or plasmapheresis in patients with postural orthostatic tachycardia syndrome (POTS). J Neurol. (2023) 270:233&#x2013;9. 10.1007/s00415-022-11344-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11344-z</ArticleId><ArticleId IdType="pubmed">36008726</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Stewart JM. Post-Lyme syndrome&#x2013;associated polyneuropathy treated with immune immunoglobulin and a luteolin-containing formulation. J Clin Psychopharmacol. (2016) 36:290. 10.1097/JCP.0000000000000504</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCP.0000000000000504</ArticleId><ArticleId IdType="pubmed">27035494</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibn Hadj Amor H, Jdidi J, Torjmen S, Kraiem S, Hammami R, et al. . Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights From TUN-EndCOV Study. Front Cardiovasc Med. (2021) 8:745758. 10.3389/fcvm.2021.745758</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A, Vecchi&#xe9; A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, et al. . Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. (2021) 21:319&#x2013;29. 10.1038/s41577-021-00536-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00536-9</ArticleId><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, et al. . Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID/post-acute sequelae of COVID-19 (PASC). Cardiovasc Diabetol. (2022) 21:1&#x2013;17. 10.1186/s12933-022-01579-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellati TJ, Burns MJ, Ficazzola MA, Furie MB. Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro. Infect Immun. (1995) 63:4439&#x2013;47. 10.1128/iai.63.11.4439-4447.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/iai.63.11.4439-4447.1995</ArticleId><ArticleId IdType="pmc">PMC173632</ArticleId><ArticleId IdType="pubmed">7591083</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellati TJ, Abrescia LD, Radolf JD, Furie MB. Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro. Infect Immun. (1996) 64:3180&#x2013;7. 10.1128/iai.64.8.3180-3187.1996</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/iai.64.8.3180-3187.1996</ArticleId><ArticleId IdType="pmc">PMC174205</ArticleId><ArticleId IdType="pubmed">8757851</ArticleId></ArticleIdList></Reference><Reference><Citation>Goehler LE, Relton JK, Dripps D, Kiechle R, Tartaglia N, Maier SF, et al. . Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res Bull. (1997) 43:357&#x2013;64. 10.1016/S0361-9230(97)00020-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0361-9230(97)00020-8</ArticleId><ArticleId IdType="pubmed">9227848</ArticleId></ArticleIdList></Reference><Reference><Citation>Goehler LE, Gaykema RPA, Opitz N, Reddaway R, Badr N, Lyte M. Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun. (2005) 19:334&#x2013;44. 10.1016/j.bbi.2004.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2004.09.002</ArticleId><ArticleId IdType="pubmed">15944073</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallaher ZR Ryu V, Herzog T, Ritter RC, Czaja K. Changes in microglial activation within the hindbrain, nodose ganglia, and the spinal cord following subdiaphragmatic vagotomy. Neurosci Lett. (2012) 513:31&#x2013;6. 10.1016/j.neulet.2012.01.079</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2012.01.079</ArticleId><ArticleId IdType="pmc">PMC3302977</ArticleId><ArticleId IdType="pubmed">22342909</ArticleId></ArticleIdList></Reference><Reference><Citation>Aucott JN, Soloski MJ, Rebman AW, Crowder LA, Lahey LJ, Wagner CA, et al. . CCL19 as a chemokine risk factor for posttreatment Lyme disease syndrome: a prospective clinical cohort study. Clin Vaccine Immunol. (2016) 23:757&#x2013;66. 10.1128/CVI.00071-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00071-16</ArticleId><ArticleId IdType="pmc">PMC5014924</ArticleId><ArticleId IdType="pubmed">27358211</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacek E, Fallon BA, Chandra A, Crow MK, Wormser GP, Alaedini A. Increased IFN&#x3b1; activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits. J Neuroimmunol. (2013) 255:85&#x2013;91. 10.1016/j.jneuroim.2012.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2012.10.011</ArticleId><ArticleId IdType="pmc">PMC3557545</ArticleId><ArticleId IdType="pubmed">23141748</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. (2007) 117:289&#x2013;96. 10.1172/JCI30555</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI30555</ArticleId><ArticleId IdType="pmc">PMC1783813</ArticleId><ArticleId IdType="pubmed">17273548</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex&#x2014;linking immunity and metabolism. Nat Rev Endocrinol. (2012) 8:743&#x2013;54. 10.1038/nrendo.2012.189</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2012.189</ArticleId><ArticleId IdType="pmc">PMC4082307</ArticleId><ArticleId IdType="pubmed">23169440</ArticleId></ArticleIdList></Reference><Reference><Citation>Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, et al. . Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. (2000) 405:458&#x2013;62. 10.1038/35013070</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35013070</ArticleId><ArticleId IdType="pubmed">10839541</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopman FA, Chavan SS, Miljko S, Grazio S, Sokolovic S, Schuurman PR, et al. . Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Nat Acad Sci. (2016) 113:8284&#x2013;9. 10.1073/pnas.1605635113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605635113</ArticleId><ArticleId IdType="pmc">PMC4961187</ArticleId><ArticleId IdType="pubmed">27382171</ArticleId></ArticleIdList></Reference><Reference><Citation>Huffman WJ, Subramaniyan S, Rodriguiz RM, Wetsel WC, Grill WM, Terrando N. Modulation of neuroinflammation and memory dysfunction using percutaneous vagus nerve stimulation in mice. Brain Stimul. (2019) 12:19&#x2013;29. 10.1016/j.brs.2018.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2018.10.005</ArticleId><ArticleId IdType="pmc">PMC6301148</ArticleId><ArticleId IdType="pubmed">30337243</ArticleId></ArticleIdList></Reference><Reference><Citation>Badran BW, Huffman SM, Dancy M, Austelle CW, Bikson M, Kautz SA, et al. . A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptoms. Bioelectron Med. (2022) 8:1&#x2013;10. 10.1186/s42234-022-00094-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42234-022-00094-y</ArticleId><ArticleId IdType="pmc">PMC9402278</ArticleId><ArticleId IdType="pubmed">36002874</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson BH, Blate M, Soto T. Transcutaneous vagus nerve stimulation in the treatment of long COVID-chronic fatigue syndrome. medRxiv [Preprint]. (2022) 2022&#x2013;11. 10.1101/2022.11.08.22281807</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.11.08.22281807</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez L, Pou C, Lakshmikanth T, Zhang J, Mugabo CH, Wang J, et al. . Achieving symptom relief in patients with Myalgic encephalomyelitis by targeting the neuro-immune interface and inducing disease tolerance. bioRxiv [Preprint]. (2020) 2020&#x2013;02. 10.1101/2020.02.20.958249</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.02.20.958249</ArticleId><ArticleId IdType="pmc">PMC10148714</ArticleId><ArticleId IdType="pubmed">37255930</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrissette M, Pitt N, Gonz&#xe1;lez A, Strandwitz P, Caboni M, Rebman AW, et al. . A distinct microbiome signature in posttreatment Lyme disease patients. mBio. (2020) 11:e02310&#x2013;20. 10.1128/mBio.02310-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02310-20</ArticleId><ArticleId IdType="pmc">PMC7527730</ArticleId><ArticleId IdType="pubmed">32994327</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Riordan KJ, Collins MK, Moloney GM, Knox EG, Aburto MR, F&#xfc;lling C, et al. . Short chain fatty acids: microbial metabolites for gut-brain axis signalling. Mol Cell Endocrinol. (2022) 546:111572. 10.1016/j.mce.2022.111572</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2022.111572</ArticleId><ArticleId IdType="pubmed">35066114</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase S, Haghikia A, Wilck N, M&#xfc;ller DN, Linker RA. Impacts of microbiome metabolites on immune regulation and autoimmunity. Immunology. (2018) 154:230&#x2013;8. 10.1111/imm.12933</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12933</ArticleId><ArticleId IdType="pmc">PMC5980218</ArticleId><ArticleId IdType="pubmed">29637999</ArticleId></ArticleIdList></Reference><Reference><Citation>Do T, Diamond S, Green C, Warren M. Nutritional implications of patients with dysautonomia and hypermobility syndromes. Curr Nutr Rep. (2021) 10:324&#x2013;33. 10.1007/s13668-021-00373-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13668-021-00373-1</ArticleId><ArticleId IdType="pmc">PMC8435108</ArticleId><ArticleId IdType="pubmed">34510391</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheney AM, Costello SM, Pinkham NV, Waldum A, Broadaway SC, Cotrina-Vidal M, et al. . Gut microbiome dysbiosis drives metabolic dysfunction in Familial dysautonomia. Nat Commun. (2023) 14:1&#x2013;12. 10.1038/s41467-023-35787-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-35787-8</ArticleId><ArticleId IdType="pmc">PMC9839693</ArticleId><ArticleId IdType="pubmed">36639365</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson D, Flattem N, Tellioglu T, Carson R, Garland E, Shannon JR, et al. . Familial orthostatic tachycardia due to norepinephrine transporter deficiency. Ann N Y Acad Sci. (2001) 940:527&#x2013;44. 10.1111/j.1749-6632.2001.tb03703.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2001.tb03703.x</ArticleId><ArticleId IdType="pubmed">11458707</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoeijmakers JG, Han C, Merkies IS, Macala LJ, Lauria G, Gerrits MM, et al. . Small nerve fibres, small hands and small feet: a new syndrome of pain, dysautonomia and acromesomelia in a kindred with a novel NaV17 mutation. Brain. (2012) 135:345&#x2013;58. 10.1093/brain/awr349</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr349</ArticleId><ArticleId IdType="pubmed">22286749</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartholomew F, Lazar J, Marqueling A, Lee-Messer C, Jaradeh S, Teng JMC. Channelopathy: a novel mutation in the SCN9A gene causes insensitivity to pain and autonomic dysregulation. Br J Dermatol. (2014) 171:1268&#x2013;70. 10.1111/bjd.13096</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.13096</ArticleId><ArticleId IdType="pubmed">24813348</ArticleId></ArticleIdList></Reference><Reference><Citation>Garland EM, Winker R, Williams SM, Jiang L, Stanton K, Byrne DW, et al. . Endothelial NO synthase polymorphisms and postural tachycardia syndrome. Hypertension. (2005) 46:1103&#x2013;10. 10.1161/01.HYP.0000185462.08685.da</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000185462.08685.da</ArticleId><ArticleId IdType="pubmed">16203873</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob G, Garland EM, Costa F, Stein CM, Xie HG, Robertson RM, et al. . &#x3b2;2-Adrenoceptor genotype and function affect hemodynamic profile heterogeneity in postural tachycardia syndrome. Hypertension. (2006) 47:421&#x2013;7. 10.1161/01.HYP.0000205120.46149.34</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000205120.46149.34</ArticleId><ArticleId IdType="pubmed">16461848</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsaik A, Allison TG, Singer W, Sletten DM, Joyner MJ, Benarroch EE, et al. . Deconditioning in patients with orthostatic intolerance. Neurology. (2012) 79:1435&#x2013;9. 10.1212/WNL.0b013e31826d5f95</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31826d5f95</ArticleId><ArticleId IdType="pmc">PMC3525293</ArticleId><ArticleId IdType="pubmed">22993288</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen CLMC, Rowe PC, Visser FC. Deconditioning does not explain orthostatic intolerance in ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome). J Transl Med. (2021) 19:193. 10.1186/s12967-021-02819-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02819-0</ArticleId><ArticleId IdType="pmc">PMC8097965</ArticleId><ArticleId IdType="pubmed">33947430</ArticleId></ArticleIdList></Reference><Reference><Citation>Petracek LS, Eastin EF, Rowe IR, Rowe PC. Orthostatic intolerance as a potential contributor to prolonged fatigue and inconsistent performance in elite swimmers. BMC Sports Sci Med Rehabil. (2022) 14:1&#x2013;11. 10.1186/s13102-022-00529-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13102-022-00529-8</ArticleId><ArticleId IdType="pmc">PMC9308026</ArticleId><ArticleId IdType="pubmed">35870963</ArticleId></ArticleIdList></Reference><Reference><Citation>Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc. (2012) 87:1196. 10.1016/j.mayocp.2012.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2012.10.013</ArticleId><ArticleId IdType="pmc">PMC3541923</ArticleId><ArticleId IdType="pubmed">23218087</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilliox L, Peltier AC, Wren PA, Anderson A, Smith AG, Singleton JR, et al. . Assessing autonomic dysfunction in early diabetic neuropathy: the survey of autonomic symptoms. Neurology. (2011) 76:1099&#x2013;105. 10.1212/WNL.0b013e3182120147</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182120147</ArticleId><ArticleId IdType="pmc">PMC3068012</ArticleId><ArticleId IdType="pubmed">21422460</ArticleId></ArticleIdList></Reference><Reference><Citation>Spahic JM, Hamrefors V, Johansson M, Ricci F, Melander O, Sutton R, et al. . Malm&#xf6; POTS symptom score: assessing symptom burden in postural orthostatic tachycardia syndrome. J Intern Med. (2023) 293:91&#x2013;9. 10.1111/joim.13566</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13566</ArticleId><ArticleId IdType="pmc">PMC10087729</ArticleId><ArticleId IdType="pubmed">36111700</ArticleId></ArticleIdList></Reference><Reference><Citation>De Wandele I, Low D, Rowe P, Simmonds JV. Exercise guidelines for postural tachycardia syndrome. In: Postural Tachycardia Syndrome: a Concise and Practical Guide to Management and Associated Conditions (2021). p. 207&#x2013;15.</Citation></Reference><Reference><Citation>Taub PR, Zadourian A, Lo HC, Ormiston CK, Golshan S, Hsu JC, et al. . Randomized trial of ivabradine in patients with hyperadrenergic postural orthostatic tachycardia syndrome. J Am Coll Cardiol. (2021) 77:861&#x2013;71. 10.1016/j.jacc.2020.12.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.12.029</ArticleId><ArticleId IdType="pubmed">33602468</ArticleId></ArticleIdList></Reference><Reference><Citation>Longo WE, Vernava AM. Prokinetic agents for lower gastrointestinal motility disorders. Dis Colon Rectum. (1993) 36:696&#x2013;708. 10.1007/BF02238599</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02238599</ArticleId><ArticleId IdType="pubmed">8348856</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson JS, Thornton AC, Ainger T, Garvy BA. Long-term high-dose immunoglobulin successfully treats long COVID patients with pulmonary, neurologic, and cardiologic symptoms. Front Immunol. (2023) 13:1033651. 10.3389/fimmu.2022.1033651</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1033651</ArticleId><ArticleId IdType="pmc">PMC9932260</ArticleId><ArticleId IdType="pubmed">36818469</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy MW. Paxlovid as a potential treatment for long COVID. Expert Opin Pharmacother. (2023) 24:1839&#x2013;43. 10.1080/14656566.2023.2262387</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14656566.2023.2262387</ArticleId><ArticleId IdType="pubmed">37731377</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Yogendra R, Guevara-Coto J, Mora-Rodriguez RA, Osgood E, Bream J, et al. . Case series: maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC). Front Med. (2023) 10:1122529 10.3389/fmed.2023.1122529</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1122529</ArticleId><ArticleId IdType="pmc">PMC9944830</ArticleId><ArticleId IdType="pubmed">36844201</ArticleId></ArticleIdList></Reference><Reference><Citation>Workman C, Boles-Ponto L, Kamholz J, Bryant A, Rudroff T. Transcranial direct current stimulation and post-COVID-19-fatigue. Brain Stimul. (2021) 14:1672&#x2013;3. 10.1016/j.brs.2021.10.268</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2021.10.268</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>